How reliable is the liquid biopsy on patients with progressing HER2 positive breast cancer with negative HER2 on liquid testing?

How does this change your treatment decisions?

Ask a clinical question

Answers grounded in the literature and physician expertise.

Related Questions

What are your top takeaways in Breast Cancer from ESMO 2025?

How would you approach treatment selection for an elderly woman with de novo metastatic HER2+ breast cancer with lung and brain mets?

How, if at all, does the spectrum of HER2 positivity impact efficacy of T-DXd in the frontline setting?

About Mednet

A community where doctors find answers to medicine's toughest questions.

Verified, credentialed physicians
45,000+ members across 23 specialties
Free CME and MOC credit

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.